MED · Longevity
Analysis proposes five explanations for failed Alzheimer’s drug trials. — Read on MED
Summary
The article proposes a taxonomy of five recurring causes and applies it retrospectively to drugs that have been tested. Its authors argue that the main causes have changed over time; the heuristic still needs validation.

















